Richard L Klemke Selected Research

Richard L Klemke Research Topics

Disease

22	Neoplasms (Cancer) 12/2021 - 05/2004
5	Neoplasm Metastasis (Metastasis) 01/2015 - 08/2009
4	Adenocarcinoma 01/2018 - 05/2012
3	Breast Neoplasms (Breast Cancer) 01/2018 - 02/2013
2	Inflammation (Inflammations) 01/2022 - 04/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 05/2012
1	Pancreatitis 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Pathologic Processes 01/2018
1	Glioma (Gliomas) 01/2018
1	Disease Progression 11/2014
1	Melanoma (Melanoma, Malignant) 02/2013
1	Brain Neoplasms (Brain Tumor) 02/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2010
1	Colonic Neoplasms (Colon Cancer) 08/2009
1	Atherosclerosis 04/2009
1	Hypercholesterolemia 04/2009
1	Stroke (Strokes) 04/2009
1	Myocardial Infarction 04/2009
1	Neuroblastoma 02/2008
1	Alzheimer Disease (Alzheimer's Disease) 01/2008
1	Rheumatoid Arthritis 01/2008
1	Skin Neoplasms (Skin Cancer) 04/2006

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2006
4	Phosphotransferases (Kinase)IBA 05/2012 - 03/2010
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2006
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2018 - 04/2006
3	ProteomeIBA 01/2012 - 08/2007
2	IntegrinsIBA 01/2017 - 01/2015
2	Peptide Initiation Factors (Initiation Factor)IBA 01/2017 - 11/2014
2	Chemotactic FactorsIBA 08/2009 - 08/2007
1	CytokinesIBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	EnzymesIBA 12/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2021
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2021
1	TOR Serine-Threonine KinasesIBA 12/2021
1	cobinamideIBA 12/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2021
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	DisintegrinsIBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	ThrombospondinsIBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2018
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2018
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2017
1	src-Family KinasesIBA 01/2015
1	Fibronectins (Fibronectin)IBA 01/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2015
1	Protein Isoforms (Isoforms)IBA 11/2014
1	ConnexinsIBA 02/2013
1	CarbenoxoloneIBA 02/2013
1	Connexin 43 (Connexin43)IBA 02/2013
1	matrigelIBA 01/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2012
1	Myosins (Myosin)IBA 06/2010
1	UbiquitinIBA 04/2010
1	Pharmaceutical PreparationsIBA 03/2010
1	Conditioned Culture MediaIBA 08/2009
1	ChemokinesIBA 08/2009
1	Macrophage Colony-Stimulating FactorIBA 08/2009
1	Lipoproteins (Lipoprotein)IBA 04/2009
1	LipidsIBA 04/2009
1	CholesterolIBA 04/2009
1	Small Molecule LibrariesIBA 02/2008
1	Somocystinamide AIBA 02/2008
1	LipopeptidesIBA 02/2008
1	Carisoprodol (Soma)FDA LinkGeneric 02/2008
1	ActininIBA 04/2006
1	Biological ProductsIBA 04/2006
1	Microfilament Proteins (Actin Binding Proteins)IBA 05/2004

Therapy/Procedure

5	Therapeutics 01/2021 - 05/2012
1	Transjugular Intrahepatic Portasystemic Shunt 12/2021
1	Aftercare (After-Treatment) 01/2021